AstraZeneca plc vs Lowe`s Companies Inc — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Lowe`s Companies Inc trades at $220.63 (market cap $122.73B). The key difference: AstraZeneca plc is far larger — about 2× Lowe`s Companies Inc's market cap, and Lowe`s Companies Inc pays the higher dividend (2.28%). Which is the better fit depends on your goals.
| AZN | LOW | |
|---|---|---|
Market Cap | $250.84B | $122.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $287.39 |
52-Week Low | $147.06 | $201.92 |
Enterprise Value | $278.12B | $164.48B |
Dividend Yield | 1.97% | 2.28% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →